Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema

Affiliations

• ¹ Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Budapest, Hungary.
• ² Allergy, Immunology, and Angioedema Center, Barzilai University Medical Center, Ashkelon, Israel.
• ³ Allergy Department, Hospital La Paz Institute for Health Research (IdiPAZ), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain.
• ⁴ Hospital Universitario Infantil de San José and Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
• ⁵ Bnai Zion Medical Center, Technion-Israel Institute of Technology, Haifa, Israel.
• ⁶ Takeda Pharmaceutical Company Limited, Lexington, MA, USA.
• ⁷ Department of Dermatology, Medical University of Graz, Graz, Austria.